BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the ...
Wave Life Sciences (NASDAQ:WVE) said Takeda (NYSE:TAK) has elected not to exercise its option to further develop its Huntington’s disease treatment candidate WVE-003. As a result, Wave (WVE) is now ...
Handheld radios prior to a TSM waveform exercise in February 2020. (US Army) The US Department of Defense (DoD) is launching a new development initiative geared towards improving waveform resiliency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results